Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.
Oizumi S, Takamura K, Harada T, Tachihara M, Morikawa N, Honda R, Watanabe S, Asao T, Kunisaki M, Fukuhara T, Noro R, Kikuchi E, Tsutani Y, Tenma T, Kobayashi K, Dosaka-Akita H; North East Japan Study Group, Hokkaido Lung Cancer Clinical Study Group. Oizumi S, et al. Among authors: tsutani y. Int J Clin Oncol. 2022 Apr;27(4):676-683. doi: 10.1007/s10147-021-02113-5. Epub 2022 Jan 29. Int J Clin Oncol. 2022. PMID: 35092535 Clinical Trial.
Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer.
Watanabe SI, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Saji H, Yoshioka H, Zenke Y, Aoki T, Tsutani Y, Okada M; Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). Watanabe SI, et al. Among authors: tsutani y. Jpn J Clin Oncol. 2017 Dec 1;47(12):1112-1118. doi: 10.1093/jjco/hyx147. Jpn J Clin Oncol. 2017. PMID: 29136212 Review.
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.
Tsutani Y, Miyata Y, Masuda T, Fujitaka K, Doi M, Awaya Y, Kuyama S, Kitaguchi S, Ueda K, Hattori N, Okada M. Tsutani Y, et al. BMC Cancer. 2018 Dec 10;18(1):1231. doi: 10.1186/s12885-018-5146-3. BMC Cancer. 2018. PMID: 30526545 Free PMC article. Clinical Trial.
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer.
Nakanishi Y, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Mimae T, Nakashima T, Miyamoto S, Tsutani Y, Iwamoto H, Fujitaka K, Miyata Y, Hamada H, Okada M, Hattori N. Nakanishi Y, et al. Among authors: tsutani y. Int J Clin Oncol. 2020 Jan;25(1):74-81. doi: 10.1007/s10147-019-01539-2. Epub 2019 Sep 17. Int J Clin Oncol. 2020. PMID: 31531785
Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE).
Tanaka K, Tsutani Y, Wakabayashi M, Mizutani T, Aokage K, Miyata Y, Kuroda H, Saji H, Watanabe SI, Okada M; behalf of the Lung Cancer Surgical Study Group/Japan Clinical Oncology Group. Tanaka K, et al. Among authors: tsutani y. Jpn J Clin Oncol. 2020 Sep 5;50(9):1076-1079. doi: 10.1093/jjco/hyaa092. Jpn J Clin Oncol. 2020. PMID: 32548619 Clinical Trial.
A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study).
Shimoyama R, Tsutani Y, Wakabayashi M, Katayama H, Fukuda H, Suzuki K, Watanabe SI; Lung Cancer Surgical Study Group. Shimoyama R, et al. Among authors: tsutani y. Jpn J Clin Oncol. 2020 Sep 28;50(10):1209-1213. doi: 10.1093/jjco/hyaa107. Jpn J Clin Oncol. 2020. PMID: 32687185 Clinical Trial.
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer.
Yotsukura M, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Shiono S, Yoshioka H, Aoki T, Tsutani Y, Okada M, Watanabe SI; Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). Yotsukura M, et al. Among authors: tsutani y. Jpn J Clin Oncol. 2021 Jan 1;51(1):28-36. doi: 10.1093/jjco/hyaa187. Jpn J Clin Oncol. 2021. PMID: 33147608 Review.
Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer.
Yamaguchi M, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Shiono S, Yoshioka H, Aoki T, Tsutani Y, Okada M, Watanabe SI; Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). Yamaguchi M, et al. Among authors: tsutani y. Jpn J Clin Oncol. 2021 Mar 3;51(3):333-344. doi: 10.1093/jjco/hyaa249. Jpn J Clin Oncol. 2021. PMID: 33506253 Review.
179 results